FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Actavis Elizabeth Gabapentin Capsules Recall

Gabapentin Capsules, USP, 300 mg, Rx Only, 100 capsules per bottle, Manufactured by: Ac…

Actavis Elizabeth LLC · Elizabeth, NJ

Risk level
Class II
Reported by FDA
Jan 14, 2015
Recall ID
D-0337-2015
Check your lot numberHow we source this data

Summary

Actavis Elizabeth recalled Gabapentin Capsules starting Dec 15, 2014. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0337-2015 on Jan 14, 2015. Reason: Failed Capsule/Tablet Specifications: Actavis has received several complaint for clumping and breaking of capsules with some bottles showing popped out bottle bottom (round bottom) and creased labels from one distribution center. Status: Terminated.

Why it was recalled

Failed Capsule/Tablet Specifications: Actavis has received several complaint for clumping and breaking of capsules with some bottles showing popped out bottle bottom (round bottom) and creased labels from one distribution center.

Product description

Gabapentin Capsules, USP, 300 mg, Rx Only, 100 capsules per bottle, Manufactured by: Actavis Pharma Manufacturing Pvt. Ltd., Plot No 101, 102, 107, & 108, SIDCO Pharmaceutical Complex, Alathurt, Kanchipuram Dist-603 110, Tamlinadu, India, Distributed by: Actavis Elizabeth LLC, 700 Elmora Ave, Elizabeth, NJ 07207 USA, NDC 45963-556-11

Lot numbers, UPCs & expiration codes

Lot #s: G01960A1, Exp 09/2015, G01967A1, Exp 10/2015

Where it was sold

Puerto Rico

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0337-2015
Classification
Class II
Status
Terminated
Recall initiated
Dec 15, 2014
FDA report date
Jan 14, 2015
Quantity
24,240 Bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Actavis Elizabeth LLC

Original FDA data

Every field from FDA enforcement report D-0337-2015, exactly as published.

Show all FDA fields
City
Elizabeth
State
NJ
Status
Terminated
Country
United States
Event ID
70001
Address
200 Elmora Ave
Code information
Lot #s: G01960A1, Exp 09/2015, G01967A1, Exp 10/2015
Postal code
07202-1106
Report date
Jan 14, 2015
Product type
Drugs
Recall number
D-0337-2015
Classification
Class II
Recalling firm
Actavis Elizabeth LLC
Product quantity
24,240 Bottles
Termination date
Nov 20, 2015
Reason for recall
Failed Capsule/Tablet Specifications: Actavis has received several complaint for clumping and breaking of capsules with some bottles showing popped out bottle bottom (round bottom) and creased labels from one distribution center.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Gabapentin Capsules, USP, 300 mg, Rx Only, 100 capsules per bottle, Manufactured by: Actavis Pharma Manufacturing Pvt. Ltd., Plot No 101, 102, 107, & 108, SIDCO Pharmaceutical Complex, Alathurt, Kanchipuram Dist-603 110, Tamlinadu, India, Distributed by: Actavis Elizabeth LLC, 700 Elmora Ave, Elizabeth, NJ 07207 USA, NDC 45963-556-11
Distribution pattern
Puerto Rico
Recall initiation date
Dec 15, 2014
Initial firm notification
Letter
Center classification date
Jan 8, 2015

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0337-2015, published Jan 14, 2015. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls